Note: Ingredients listed on restricted chemical lists
EC/CAS
68649-42-3
Name of the chemical
Phosphorodithioic acid, O,O-di-C1-14-alkyl esters, zinc salts
Concentration
>=1.5-<5%
General Information
Version
3.4
Revision date
2013-10-24
Product name
VAL PLEX GREASE
Emergency telephone
1-800-274-5263
Icons in SDS
Company Information
company name
Ashland
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview Appearance: liquid, gel, red CAUTION! PROLONGED OR REPEATED CONTACT MAY DRY THE SKIN AND CAUSE IRRITATION AND BURNS.
Principle Routes of Exposure
Inhalation, Skin absorption, Skin contact, Eye Contact, Ingestion Eye contact May cause mild eye irritation. Symptoms include stinging, tearing, and redness. Skin contact May cause slight skin irritation. Prolonged or repeated contact may dry the skin. Symptoms may include redness, burning, and drying and cracking of skin, skin burns, and other skin damage. Ingestion Swallowing small amounts of this material during normal handling is not likely to cause harmful effects. Swallowing large amounts may be harmful. Inhalation It is possible to breathe this material under certain conditions of handling and use (for example, during heating, spraying, or stirring). Breathing small amounts of this material during normal handling is not likely to cause harmful effects. Breathing large amounts may be harmful. Symptoms are not expected at air concentrations below the recommended exposure limits, if applicable (see Section 8.).
Medical Conditions Generally Aggravated by Exposure
Preexisting disorders of the following organs (or organ systems) may be aggravated by exposure to this material:, Skin, lung (for example, asthma-like conditions) Symptoms 3087 Signs and symptoms of exposure to this material through breathing, swallowing, and/or passage of the material through the skin may include:, stomach or intestinal upset (nausea, vomiting, diarrhea), irritation (nose, throat, airways) Target Organs No data Carcinogenicity This material is not listed as a carcinogen by the International Agency for Research on Cancer (IARC),